Enzon Pharmaceuticals Widgets and Gadgets
Macroaxis provides equity-specific financial widgets, gadgets, and otc stock tickers for Enzon Pharmaceuticals. These reusable financial scriptlets can be easily installed within any HTML-based document by an end user without requiring any additional resources. Macroaxis equity widgets for Enzon Pharmaceuticals can be integrated to existing financial portals, investment related sites, business school online boards, or personal blogs. Enzon Pharmaceuticals widgets and tickers can be used to distribute on-demand financial information including other stocks, funds, ETFs as well as world market quotes, changes, and fundamentals. This page provides just few examples of widgets and tickers designed for Enzon Pharmaceuticals. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation.
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- ENZN Enzon Pharmaceuticals
- ENZN 0.0 0.0
- Low 0.0
- High 0.0
- Return On Equity -0.016
- Return On Asset -0.0138
- Operating Margin (36.28) %
- Current Valuation 17.63 M
- Shares Outstanding 74.21 M
- Shares Owned By Insiders 10.70 %
- Shares Owned By Institutions 48.58 %
- Number Of Shares Shorted 259.38 K
- Price To Earning 1.52 X
- Price To Book 7.41 X
- Price To Sales 669.36 X
- Revenue 701 K
- Gross Profit 701 K
- EBITDA (469 K)
- Net Income (469 K)
- Cash And Equivalents 46.79 M
- Cash Per Share 0.63 X
- Debt To Equity 1.46 %
- Current Ratio 125.26 X
- Book Value Per Share 0.04 X
- Cash Flow From Operations (501 K)
- Short Ratio 1.71 X
- Earnings Per Share (0.04) X
- Target Price 14.0
- Number Of Employees 6
- Beta 0.17
- Market Capitalization 19.72 M
- Total Asset 47.75 M
- Retained Earnings (75.61 M)
- Working Capital 6.98 M
- Current Asset 11.78 M
- Current Liabilities 4.8 M
- Z Score -1.4
- Annual Yield 0.65 %
- Net Asset 47.75 M
Market Snapshot Widget Example
DAX Index Germany | 22,892 0.47 | |
Taiwan Weighted Taiwan | 22,209 0.75 | |
PSI 20 Stock Portugal | 6,798 0.92 | |
CROBEX Croatia | 3,321 0.23 | |
Budapest SE Hungary | 89,972 0.36 | |
IDX 30 Jakarta Indonesia | 361.51 2.31 | |
ISEQ 20 Price Ireland | 1,840 0.25 | |
NYSE Comp USA | 19,454 0.42 | |
Tel Aviv 35 Israel | 2,502 0.12 | |
Coreshares Index Tracker South Afric | 1,126 0.35 | |
IPC MEXICO Mexico | 52,672 0.81 | |
KL Technology Malaysia | 49.80 0.46 | |
IBEX 35 Index Spain | 13,350 0.33 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 4,260 0.59 | |
SPASX Dividend Opportunities Australia | 1,636 0.73 | |
HNX 30 Vietnam | 502.01 1.15 | |
Bucharest BET-NG Romania | 1,262 0.07 | |
AMS Small Cap Netherlands | 1,406 0.34 | |
Oslo Exchange Mutual Norway | 1,486 0.41 | |
BEL Small Belgium | 8,659 0.3 | |
Basic Materials Brazil | 5,485 0.69 | |
Swiss Leader Price Switzerland | 2,108 0.39 | |
Fondo Mutuo ETF Chile | 1,552 0.06 | |
Athens General Comp Greece | 1,697 0.34 | |
Stock Exchange Of Thailand | 1,187 0.41 | |
PX Prague Stock Czech Repub | 2,080 0.12 | |
THE PHILIPPINE STOCK Philippines | 6,267 0.89 | |
WIG 30 Poland | 3,473 0.85 | |
BIST Electricity Turkey | 436.46 6.08 |
Investing Ideas
In addition to having Enzon Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Enzon Pharmaceuticals
Compare Enzon Pharmaceuticals To Peers
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Enzon Pharmaceuticals information on this page should be used as a complementary analysis to other Enzon Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Enzon OTC Stock
If you are still planning to invest in Enzon Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enzon Pharmaceuticals' history and understand the potential risks before investing.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |